Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

South Korea prioritizes AI transformation of diagnostic imaging devices to meet growing demand in hospitals, says GlobalData

Several South Korean healthtech startups that offer artificial intelligence (AI)-based imaging solutions are increasingly partnering with domestic and international multinationals to meet the growing demand in hospitals. Against this backdrop, South Korea diagnostic imaging market is expected to grow at a compound annual growth rate of approximately 5% between 2023 and 2030, forecasts GlobalData, a […]
Read more

Early detection of lung cancer using biopsy devices vital to combat rising mortality rate, says GlobalData

Lung Cancer Awareness Month is intended to raise awareness of what is the world’s deadliest cancer, with the International Agency for Research on Cancer estimating three million people will die from the disease globally by 2040. Therefore, early detection of lung cancer using biopsy devices is critical to improving recovery rates, says GlobalData, a leading […]
Read more

Sports-related head injuries could expand indications of neurology markets, says GlobalData

Both amateur and professional footballers are at a higher risk of head injuries from high-impact head contact during training and gameplay. With the incidence of sports-related injury increasing, growth within neurological medical device markets can also be expected—with hydrocephalus shunts, interventional neuroradiology, and neuromodulation markets estimated to be worth $0.5 billion, $4.5 billion, and $10.7 […]
Read more

Continuous glucose monitoring devices could become main glucose monitoring solution in the US, says GlobalData

Continuous glucose monitoring (CGM) devices could become the leading solution for a growing diabetes population in the US if the FDA’s proposed changes to reimbursement go ahead, says GlobalData. The leading data and analytics company notes that fully reimbursed CGM systems would provide relief to a huge number of diabetes patients, the majority of which currently […]
Read more

Novel technologies and therapies for Parkinson’s disease seeing greater interest by big pharma, says GlobalData

Due to the high-risk nature of drugs being developed for neurology diseases, most product launches in the recent history of Parkinson’s disease have been the result of strategic partnerships for marketing and sales, with few exceptions. Therefore, large pharmaceutical companies such as Merck, Roche, Novartis, and AbbVie often prefer to invest in therapies that are […]
Read more

ECG implants and smartwatches vital for early detection of heart failure and COVID-19 management, says GlobalData

Remote patient monitoring (RPM) devices with electrocardiographic (ECG) capabilities such as medically implantable monitors and more consumer-focused products such as AliveCor’s KardiaMobile 6L and Apple’s Series 4 and 5 represent the future of cardiac monitoring, according to GlobalData. The leading data and analytics company notes that these devices’ ability to track early heart damage and […]
Read more

Webinar invite, cardiovascular devices: COVID-19 proved a market share disruptor among the big seven public cardiovascular medtech companies, says GlobalData

On Tuesday, 29 November, 2022, at 11:00 (ET), the Medical Devices team at GlobalData will host a webinar taking a deep dive into historic market revenue trends of cardiovascular medical device companies. Click here to register, and find out: How the seven leading public medical device companies in the cardiovascular devices sector performed during COVID-19 […]
Read more

In vitro diagnostics expands reach to meet pent-up demand for other diseases and better position manufacturers for market volatilities, says GlobalData

Long after the pandemic subsides, countries will find themselves with an increased capacity for in vitro diagnostics (IVD) testing, including clinical-grade genomic sequencing utilized to diagnose complex diseases, such as cancers, says GlobalData. The leading data and analytics company notes that diagnostic tests for metabolic disorders (cholesterol) and other infectious diseases (hepatitis, HIV) will also […]
Read more

NeuroPace’s RNS system may prove to be an essential option to treating idiopathic generalised epilepsy at the source, says GlobalData

Following NeuroPace’s announcement that its first patient has been implanted with its responsive neurostimulation (RNS) system during the ongoing NAUTILUS clinical trials; Aidan Robertson, Medical Analyst at GlobalData, a leading data and analytics company, offers his view: “As the prevalence of epilepsy is increasing, there will be growing demand for non-medicated solutions as the perception […]
Read more

Regulators should address complexities to keep up with AI advancements in medical devices, says GlobalData

Regulatory bodies in the healthcare industry are failing to keep up with the accelerating adoption of artificial intelligence (AI) in medical devices. As many AI technologies have continuous learning capabilities, regulatory bodies such as the FDA and Health Canada should focus on creating a regulatory framework that would allow for ongoing changes, says GlobalData, a […]
Read more

ACE Xtend’s approval will help shorten interventional radiology percutaneous procedure durations, says GlobalData

The recent FDA approval of the ACE Xtend Remote Control Unit will have a positive impact on patients and healthcare personnel as it helps in shortening the durations of interventional percutaneous procedures, says GlobalData, a leading data and analytics company. The XACT ACE Robotic System is a device designed to increase the success of interventional […]
Read more

Automated cath labs to enhance cardiovascular care in India, says GlobalData

GE Healthcare has recently introduced its first made-in-India artificial intelligence (AI) enabled cath lab diagnostic imaging platform, the Optima IGS 320. This sophisticated interventional cardiology system will guide non-invasive cardiovascular procedures with better precision and versatility, says GlobalData, a leading data and analytics company. GlobalData forecasts the Indian cardiovascular devices market to grow at a […]
Read more

AI-enabled made-in-India products to advance patient care in India, says GlobalData

With the rise of artificial intelligence (AI) and machine learning-focused healthtech startups in India, big companies such as Oracle Corp are looking for opportunities to invest and expand their footprint in the country. Against this backdrop, AI-enabled made-in-India products will offer advanced healthcare solutions and improve patient care in India, says GlobalData, a leading data, […]
Read more

New NHMRC Centre to facilitate personalized breast cancer screening in Australia, says GlobalData

The University of Melbourne has recently launched My Breast cancer RISK Centre (MyBRISK), a new National Health and Medical Research Council Centre (NHMRC) for Research Excellence, to apply a holistic risk-based approach to breast cancer screening. This is expected to increase the diagnosis rate and facilitate early cancer detection and personalized screening, thereby reducing the […]
Read more
1 … 25 26 27 28 29 … 51